| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $494K | — | -11.2% |
| Cost of Revenue | $114K | — | -44.9% |
| R&D Expense | $17.5M | — | +6.1% |
| SG&A Expense | $6.9M | — | +22.2% |
| Operating Income | -$24.0M | — | -10.2% |
| Interest Expense | $27K | — | +3.8% |
| Pre-tax Income | -$22.4M | — | -2.2% |
| Income Tax | $492K | — | — |
| Net Income | -$23.0M | — | -5.3% |
| EPS (Basic) | -$0.28 | — | +54.1% |
| EPS (Diluted) | -$0.28 | — | +54.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $231K | +621.9% | +22.2% |
| Inventory | $122K | -19.7% | -66.5% |
| Current Assets | $286.7M | +1728.7% | +441.1% |
| Total Assets | $294.7M | +1181.6% | +401.3% |
| Current Liabilities | $13.7M | -35.9% | -5.1% |
| Long-term Debt | $18K |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$28.7M | — | -33.5% |
| Capital Expenditures | $137K | — | -44.8% |
| Investing Cash Flow | -$182K | — | -116.4% |
| Financing Cash Flow | $299.5M | — | — |
| Free Cash Flow | -$28.8M | — | -32.6% |
| -40.0% |
| Total Liabilities | $16.3M | -29.8% | +4.0% |
| Stockholders' Equity | $278.4M | — | +543.7% |